Stay updated on Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe ClinicalTrials.gov page’s displayed site revision changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check22 days agoChange DetectedA banner announces changes to NIH websites and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.9%

- Check29 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1. The study record content is unchanged.SummaryDifference0.1%

- Check36 days agoChange DetectedThe ClinicalTrials.gov site's displayed revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check57 days agoChange DetectedThe record history shows a new Revision: v3.7.0 replacing the previous v3.6.6, indicating a page version update rather than changes to the study details.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry v3.6.6 was added to the record history, and the previous revision v3.6.5 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.